Florian Karreth
Florian Karreth
Geverifieerd e-mailadres voor moffitt.org
Geciteerd door
Geciteerd door
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
GM DeNicola, FA Karreth, TJ Humpton, A Gopinathan, C Wei, K Frese, ...
Nature 475 (7354), 106-109, 2011
Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
Y Tay, L Kats, L Salmena, D Weiss, SM Tan, U Ala, F Karreth, L Poliseno, ...
Cell 147 (2), 344-357, 2011
In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma
FA Karreth, Y Tay, D Perna, U Ala, SM Tan, AG Rust, G DeNicola, ...
Cell 147 (2), 382-395, 2011
ceRNA cross-talk in cancer: when ce-bling rivalries go awry
FA Karreth, PP Pandolfi
Cancer discovery 3 (10), 1113-1121, 2013
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885
AJ King, DR Patrick, RS Batorsky, ML Ho, HT Do, SY Zhang, R Kumar, ...
Cancer research 66 (23), 11100-11105, 2006
Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments
U Ala, FA Karreth, C Bosia, A Pagnani, R Taulli, V Léopold, Y Tay, ...
Proceedings of the National Academy of Sciences 110 (18), 7154-7159, 2013
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo
FA Karreth, M Reschke, A Ruocco, C Ng, B Chapuy, V Léopold, ...
Cell 161 (2), 319-332, 2015
Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro …
R Gruber, F Karreth, B Kandler, G Fuerst, A Rot, MB Fischer, G Watzek
Platelets 15 (1), 29-35, 2004
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
L Kenner, A Hoebertz, FT Beil, N Keon, F Karreth, R Eferl, H Scheuch, ...
The Journal of cell biology 164 (4), 613-623, 2004
The Fos‐related antigen Fra‐1 is an activator of bone matrix formation
R Eferl, A Hoebertz, AF Schilling, M Rath, F Karreth, L Kenner, M Amling, ...
The EMBO journal 23 (14), 2789-2799, 2004
Germline Brca2 heterozygosity promotes KrasG12D-driven carcinogenesis in a murine model of familial pancreatic cancer
F Skoulidis, LD Cassidy, V Pisupati, JG Jonasson, H Bjarnason, ...
Cancer cell 18 (5), 499-509, 2010
Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis
F Karreth, DA Tuveson
Cancer biology & therapy 3 (11), 1058-1059, 2004
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model
D Perna, FA Karreth, AG Rust, PA Perez-Mancera, M Rashid, F Iorio, ...
Proceedings of the National Academy of Sciences 112 (6), E536-E545, 2015
C-Raf is required for the initiation of lung cancer by K-RasG12D
FA Karreth, KK Frese, GM DeNicola, M Baccarini, DA Tuveson
Cancer discovery 1 (2), 128-136, 2011
Platelets are mitogenic for periosteum‐derived cells
R Gruber, F Karreth, F Frommlet, MB Fischer, G Watzek
Journal of Orthopaedic Research 21 (5), 941-948, 2003
JunD regulates lymphocyte proliferation and T helper cell cytokine expression
A Meixner, F Karreth, L Kenner, EF Wagner
The EMBO journal 23 (6), 1325-1335, 2004
The AP1 transcription factor Fra2 is required for efficient cartilage development
F Karreth, A Hoebertz, H Scheuch, R Eferl, EF Wagner
Oxford University Press for The Company of Biologists Limited 131 (22), 5717 …, 2004
Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism
R Gruber, F Karreth, MB Fischer, G Watzek
Bone 30 (5), 726-732, 2002
Modelling oncogenic Ras/Raf signalling in the mouse
FA Karreth, DA Tuveson
Current opinion in genetics & development 19 (1), 4-11, 2009
C-Raf inhibits MAPK activation and transformation by B-RafV600E
FA Karreth, GM DeNicola, SP Winter, DA Tuveson
Molecular cell 36 (3), 477-486, 2009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20